Globe NewswireJun 22, 2026Market news
Creative Medical Technology said the FDA cleared an expansion of its ADAPT trial for CELZ-201, adding 15 patients with chronic lower back pain linked to degenerative disc disease and ongoing opioid use.
All companies
Start with eToroCreative Medical Technology expands trial after FDA clearance
CR
Creative Medical Technology Holdings Inc
CELZIPO Upcoming
IPO UpcomingUnited States0 markets
Official IPO
Filed· Listing market: United StatesExpected IPO date
To be announced
Final IPO price
To be announced
Shares offered
To be announced
IPO raise
To be announced
Sources: sec-edgar
No live market is quoted for Creative Medical Technology Holdings Inc yet. Get in line for IPO-day access through a broker in the meantime.
eToro
Invest in stocks once they list with eToro
Trade stocks, ETFs and crypto from one simple account.
Latest Creative Medical Technology Holdings Inc IPO news
Recent sourced articles classified for IPO relevance, with platform-access noise filtered out where possible.
Creative Medical Technology Holdings Inc IPO — frequently asked questions
- When is Creative Medical Technology Holdings Inc's IPO?
- Creative Medical Technology Holdings Inc has not announced an official IPO date yet — it is still privately held. We update this page as soon as an IPO date, filing or price range is reported.
- What is Creative Medical Technology Holdings Inc's expected IPO price?
- Creative Medical Technology Holdings Inc's IPO price has not been set yet. The price range is usually disclosed in the final prospectus, shortly before the company lists.
- Is Creative Medical Technology Holdings Inc publicly traded?
- Not yet — Creative Medical Technology Holdings Inc is still a private company, so its shares aren't available on public exchanges. IPO Tracker monitors pre-IPO markets, IPO filings and the IPO calendar, so Creative Medical Technology Holdings Inc's pre-IPO price and IPO date will appear here as soon as they're available.